We are live on ! Find out more
CH

CVI Holdings Portfolio holdings

AUM $116M
1-Year Est. Return 5.68%
This Fund
S&P 500
This Quarter Est. Return
+12.91%
1 Year Est. Return
+5.68%
3 Year Est. Return
+25.77%
5 Year Est. Return
+327.29%
10 Year Est. Return
–
AUM
$536M
AUM Growth
+$290M
Cap. Flow
+$258M
Cap. Flow %
48.25%
Top 10 Hldgs %
35.44%
Holding
227
New
144
Increased
1
Reduced
9
Closed
45

Top Buys

Rank Stock Value
1
ACIC.U
Atlas Crest Investment Corp. Units, each consisting of one Class A common stock, and one-third of on
ACIC.U
+$49M
2
SVSVU
Spring Valley Acquisition Corp. Unit
SVSVU
+$20.7M
3
TVACU
Thayer Ventures Acquisition Corporation Units
TVACU
+$15.6M
4
CFIVU
CF Acquisition Corp. IV Unit
CFIVU
+$12.9M
5
GFX.U
Golden Falcon Acquisition Corp. Units, each consisting of one share of Class A Common Stock and one-half of one Warrant
GFX.U
+$10.4M

Top Sells

Rank Stock Value
1
FCEL icon
FuelCell Energy
FCEL
+$40.7M
2
VLDR
Velodyne Lidar, Inc. Common Stock
VLDR
+$28M
3
QELLU
Qell Acquisition Corp. Unit
QELLU
+$7.62M
4
SNPR.U
Tortoise Acquisition Corp. II Units, each consisting of one Class A ordinary share and one-fourth of
SNPR.U
+$5.36M
5
CKPT
Checkpoint Therapeutics
CKPT
+$5.02M

Sector Composition

Rank Sector Weight
1 Financials 10.37%
2 Healthcare 8.84%
3 Consumer Discretionary 8.72%
4 Industrials 2.98%
5 Technology 2.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SCYX icon
51
SCYNEXIS
SCYX
$37M
$3.06M 0.57%
+50,000
New +$2.34M
BREZ
52
DELISTED
Breeze Holdings Acquisition Corp. Common Stock
BREZ
$3.04M 0.57%
+300,000
New +$3.06M
PIAI
53
DELISTED
Prime Impact Acquisition I
PIAI
$3.03M 0.57%
+300,000
New +$2.97M
YAC
54
DELISTED
Yucaipa Acquisition Corporation Class A Ordinary Shares
YAC
$3.03M 0.57%
+300,000
New +$2.98M
SKIN icon
55
SkinHealth Systems
SKIN
$87.6M
$3.01M 0.56%
+266,247
New +$2.87M
SLNO
56
DELISTED
Soleno Therapeutics
SLNO
$2.99M 0.56%
103,397
– –
CTAC.U
57
DELISTED
Cerberus Telecom Acquisition Corp. Units, each consisting of one Class A ordinary share and one-thir
CTAC.U
$2.67M 0.5%
+250,000
New +$2.54M
AJAX.U
58
DELISTED
Capri Listco Units, each consisting of one Class A ordinary share and one-fourth of one redeemable w
AJAX.U
$2.65M 0.49%
+213,545
New +$2.34M
MTACU
59
DELISTED
MedTech Acquisition Corporation Unit
MTACU
$2.63M 0.49%
+250,000
New +$2.61M
ALTUU
60
DELISTED
Altitude Acquisition Corp Unit
ALTUU
$2.59M 0.48%
+250,000
New +$2.58M
DUNEU
61
DELISTED
Dune Acquisition Corporation Unit
DUNEU
$2.55M 0.48%
+250,000
New +$2.55M
MIRM icon
62
Mirum Pharmaceuticals
MIRM
$6.87B
$2.48M 0.46%
+142,035
New +$2.79M
PDAC.U
63
DELISTED
Peridot Acquisition Corp. Units, each consisting of one Class A ordinary share, and one-half of one
PDAC.U
$2.25M 0.42%
200,000
– –
RGLS
64
DELISTED
Regulus Therapeutics
RGLS
$2.17M 0.41%
+160,772
New +$1.18M
SPRQ.U
65
DELISTED
Spartan Acquisition Corp. II Units, each consisting of one share of Class A common stock, and one-ha
SPRQ.U
$2.16M 0.4%
+200,000
New +$2.11M
CFACU
66
DELISTED
CF Finance Acquisition Corp. III Unit
CFACU
$2.15M 0.4%
+200,000
New +$2.06M
VCVCU
67
DELISTED
10X Capital Venture Acquisition Corp Unit
VCVCU
$2.13M 0.4%
+200,000
New +$2.06M
ASAQ.U
68
DELISTED
Atlantic Avenue Acquisition Corp. Units, each consisting of one share of Class A common stock and one-half of one warrant
ASAQ.U
$2.12M 0.4%
+200,000
New +$2.01M
AHACU
69
DELISTED
Alpha Healthcare Acquisition Corp Unit
AHACU
$2.12M 0.4%
200,000
– –
GHVIU
70
DELISTED
Gores Holdings VI, Inc. Unit
GHVIU
$2.12M 0.4%
+200,000
New +$2.12M
IIIIU
71
DELISTED
INSU Acquisition Corp. III Unit
IIIIU
$2.11M 0.39%
+200,000
New +$2.11M
TWCT
72
DELISTED
TWC Tech Holdings II Corp. Class A Common Stock
TWCT
$2.11M 0.39%
+200,000
New +$2.01M
OACB
73
DELISTED
Oaktree Acquisition Corp. II
OACB
$2.1M 0.39%
+200,000
New +$2.03M
PHICU
74
DELISTED
Population Health Investment Co., Inc. Unit
PHICU
$2.09M 0.39%
+200,000
New +$2.06M
ROCCU
75
DELISTED
Roth CH Acquisition II Co. Unit
ROCCU
$2.08M 0.39%
+200,000
New +$2.06M
1 2
3
4 5

Similar funds

EL
EMFO LLC Weston, Florida $112M AUM 18.79% 1-Year Est. Return
YSP
Yarra Square Partners New York $111M AUM 41.61% 1-Year Est. Return
GIM
Greenwich Investment Management Norwalk, Connecticut $109M AUM 9.72% 1-Year Est. Return
FWM
FMFE Wealth Management Syracuse, New York $108M AUM
CPG
Custom Portfolio Group Englewood, Colorado $127M AUM
WCM
Windham Capital Management Boston, Massachusetts $128M AUM 12.44% 1-Year Est. Return
ETIA
Epic Trust Investment Advisors Richland, Washington $90.8M AUM 22.03% 1-Year Est. Return
RCM
Rain Capital Management Lake Oswego, Oregon $142M AUM 15.53% 1-Year Est. Return

CVI Holdings's Q4 2020 Portfolio in Review

As of Q4 2020, CVI Holdings held 227 positions worth $536M, up 118% from $246M the previous quarter. Its ten largest holdings account for 35% of the portfolio.

CVI Holdings deployed $258M of net new capital in Q4 2020, opening 144 new positions and adding to 1 existing holding. Its largest new stake was Atlas Crest Investment Corp. Units, each consisting of one Class A common stock, and one-third of on: 4,800,000 shares worth $50.6M.

By sector, the portfolio is most concentrated in Financials at 10% of assets, up from 4.4% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was Checkpoint Therapeutics, an estimated $5.02M trimmed.

  • CVI Holdings's largest Q4 2020 buy was Atlas Crest Investment Corp. Units, each consisting of one Class A common stock, and one-third of on: 4,800,000 shares worth $50.6M.
  • CVI Holdings added most to Neptune Wellness Solutions Inc. Ordinary Shares in Q4 2020, an estimated $4.13M increase.
  • CVI Holdings's biggest Q4 2020 reduction was Checkpoint Therapeutics, cutting an estimated $5.02M.
  • CVI Holdings fully exited FuelCell Energy in Q4 2020, selling an estimated $40.7M.
  • CVI Holdings's ten largest holdings make up 35% of its $536M portfolio in Q4 2020.
  • CVI Holdings opened 144 new positions and closed 45 in Q4 2020.
  • CVI Holdings's portfolio value rose 118% quarter-over-quarter to $536M.

Based on CVI Holdings's 13F filing for Q4 2020, filed 16 Feb 2021.